Printer Friendly
The Free Library
19,573,962 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

ADVISORY/Lorus Therapeutics To Host Annual General Meeting Wednesday, November 15, 2000.


Business Editors

ADVISORY . . . for Wednesday, Nov. 15

--(BUSINESS WIRE)

Lorus (TSE See Tokyo Stock Exchange.

TSE

1. See Tokyo Stock Exchange (TSE).

2. See Toronto Stock Exchange (TSE).
:LOR LOR Letter Of Reprimand (military)
LoR Lord of the Rings (J.R.R. Tolkien)
LOR Learning Object Repository
LOR Linux.Org.
.)(OTCBB OTCBB

See OTC Bulletin Board (OTCBB).
:LORFF)



WHAT:   Lorus Therapeutics Inc. ("Lorus") invites shareholders,
        financial analysts and media to attend its Annual General
        Meeting at the Canadian Bar Association.

RSVP:   Kindly confirm your attendance by calling: (416) 599-6152 or
        by emailing ir@lorusthera.com.

WHEN:   Wednesday, November 15, 2000, from 4:00 p.m. to 6:00 p.m. EST.

WHERE:  The Canadian Bar Association
        20 Toronto Street
        Toronto, Ontario
        Salons 1, 2 and 3

WHO:    Presentations will be made by:
        Philippe G. Lacaille, Chairman and Chief Executive Officer

And

        Dr. Jim Wright, President and Chief Scientific Officer


Lorus is a biopharmaceutical company focused on the research and development of cancer therapies. Lorus' goal is to capitalize on Cap´i`tal`ize on`   

v. t. 1. To turn (an opportunity) to one's advantage; to take advantage of (a situation); to profit from; as, to capitalize on an opponent's mistakes s>.
 its research, pre-clinical, clinical and regulatory expertise by developing new drug candidates that can be used, either alone, or in combination, to successfully manage cancer. Through an active acquisition and in-licensing program, Lorus is building a portfolio of promising anti-cancer drugs. Late-stage clinical developments and marketing will be done in cooperation with strategic pharmaceutical partners. Founded in 1986, Lorus Therapeutics Inc. is a public company listed on the Toronto Stock Exchange Toronto Stock Exchange (TSE)

Canada's largest stock exchange, trading approximately 1,200 company stocks and 33 options.
 under the symbol LOR, and on the OTC OTC

See: Over-the-counter.


OTC

See over-the-counter market (OTC).
 BB exchange under the symbol LORFF. Lorus Therapeutics Inc.'s press releases are available through the Company's Internet site: www.lorusthera.com.
COPYRIGHT 2000 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2000, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:1CANA
Date:Nov 13, 2000
Words:226
Previous Article:Craig Gentner to Retire From Redback Networks in First Quarter 2001 Due to Family Medical Issues.
Next Article:ADVISORY/Nintendo Box Cover Photo of Mickey's Speedway USA is available on BW PhotoWire/AP PhotoExpress, NewsCom, PressLink and Business Wire's Web...
Topics:



Related Articles
Lorus Therapeutics Reports Second Quarter Results.
LORUS' VIRULIZIN EFFECTIVE AGAINST PANCREATIC TUMORS.
Lorus Therapeutics Appoints Interim Chairman Of The Board.
Lorus Therapeutics to Present Today At BioContact Quebec 2001.
Lorus Therapeutics To Present Today At BioContact Quebec 2001.
FDA APPROVES LORUS/NCI GTI-2040 PHASE II CLINICAL TRIAL.
NUCHEM ALLOWED MOLECULES PATENT BY EUROPEAN PATENT OFFICE.
The 2004 calendar.
LORUS SIGNS VIRULIZIN SUPPLY PACT WITH BIOVECTRA.
AAHSA's San Francisco treat.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles